Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections

JAMA Intern Med. 2014 Oct;174(10):1702-4. doi: 10.1001/jamainternmed.2014.3926.

Authors

Gabriela Schmajuk¹, Kevin J Bozic², Jinoos Yazdany³

Affiliations

¹ Department of Medicine and Rheumatology, University of California, San Francisco2San Francisco Veterans Affairs Medical Center, San Francisco, California.
² Department of Orthopedic Surgery, University of California, San Francisco4Philip R. Lee Institute for Health Policy Studies, San Francisco, California.
³ Department of Medicine and Rheumatology, University of California, San Francisco.

No abstract available

MeSH terms

Aged
Aged, 80 and over
Cost-Benefit Analysis
Evidence-Based Medicine
Female
Humans
Hyaluronic Acid / administration & dosage*
Hyaluronic Acid / economics*
Injections, Intra-Articular
Knee Joint / drug effects*
Logistic Models
Male
Medicare
Osteoarthritis / drug therapy*
Osteoarthritis / economics
Treatment Outcome
United States
Viscosupplements / administration & dosage*
Viscosupplements / economics*

Substances

Viscosupplements
Hyaluronic Acid

Grants and funding